US Oncology Companion Diagnostics Market Growth Fueled by Precision Medicine Adoption
The Oncology Companion Diagnostics Market in the US is expanding as healthcare providers increasingly use companion diagnostic tests to identify cancer-related biomarkers and support treatment selection for patients receiving targeted therapies. Market Overview The global oncology companion diagnostics market size is projected to reach US$ 43.18 billion by 2034 from US$...
0 Comments 0 Shares 92 Views